NTCP opens the door for hepatitis B virus infection.

A liver bile acids transporter, sodium taurocholate cotransporting polypeptide (NTCP, encoded by SLC10A1) was recently identified as a functional receptor for hepatitis B virus (HBV) and its satellite hepatitis D virus (HDV). NTCP-complemented human hepatoma HepG2 cells (HepG2-NTCP) were shown to support infection of HBV and HDV in vitro, providing a much-needed and convenient cell culture system for the viruses. Identification of NTCP as a functional receptor for HBV has significantly advanced our understanding of the viral life cycle and opened new opportunities for developing anti-HBV interventions. This article forms part of a symposium in Antiviral Research on "An unfinished story: from the discovery of the Australia antigen to the development of new curative therapies for hepatitis B".

[1]  R. Lanford,et al.  Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion , 1993, Journal of virology.

[2]  B. Autran,et al.  Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure , 2015, Gut.

[3]  H. Varmus,et al.  The molecular biology of the hepatitis B viruses. , 1987, Annual review of biochemistry.

[4]  Sean Ekins,et al.  Quantitative NTCP pharmacophore and lack of association between DILI and NTCP Inhibition. , 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  Hussein H. Aly,et al.  Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP. , 2014, Biochemical and biophysical research communications.

[6]  R. Schwabe,et al.  Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes , 2022 .

[7]  C. Sureau,et al.  Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle. , 2014, Antiviral research.

[8]  Y. Ni,et al.  Fine Mapping of Pre-S Sequence Requirements for Hepatitis B Virus Large Envelope Protein-Mediated Receptor Interaction , 2009, Journal of Virology.

[9]  A. Neurath,et al.  Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. , 1989, Vaccine.

[10]  J. Mullins,et al.  Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA , 1986, Cell.

[11]  Wenhui Li,et al.  Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus , 2012, eLife.

[12]  Vyas Ramanan,et al.  Modeling host interactions with hepatitis B virus using primary and induced pluripotent stem cell-derived hepatocellular systems , 2014, Proceedings of the National Academy of Sciences.

[13]  M. Fälth,et al.  Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. , 2014, Gastroenterology.

[14]  C. Bréchot,et al.  Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide , 1988, Journal of virology.

[15]  M. Tao,et al.  (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes. , 2014, Antiviral research.

[16]  A. Lok,et al.  Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs. , 2015, Journal of hepatology.

[17]  P. Galle,et al.  Infectious hepatitis B virus variant defective in pre-S2 protein expression in a chronic carrier. , 1993, Virology.

[18]  M. Sugiyama,et al.  Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression* , 2014, The Journal of Biological Chemistry.

[19]  C. Ryu,et al.  In vivo neutralization of hepatitis B virus infection by an anti-preS1 humanized antibody in chimpanzees. , 2004, Virology.

[20]  S. Urban,et al.  Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. , 2005, Gastroenterology.

[21]  A. Lohse,et al.  Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism , 2014, Hepatology.

[22]  Christian Trepo,et al.  Infection of a human hepatoma cell line by hepatitis B virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  B. Stieger.  The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. , 2011, Handbook of experimental pharmacology.

[24]  M. Tschapka,et al.  Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes , 2013, Proceedings of the National Academy of Sciences.

[25]  J. Taylor,et al.  Hepatitis delta virus. , 2006, Virology.

[26]  D. Glebe,et al.  Role of glycosaminoglycans for binding and infection of hepatitis B virus , 2007, Cellular microbiology.

[27]  C. Guguen-Guillouzo,et al.  Infection Process of the Hepatitis B Virus Depends on the Presence of a Defined Sequence in the Pre-S1 Domain , 1999, Journal of Virology.

[28]  S. Urban,et al.  Viral and cellular determinants involved in hepadnaviral entry. , 2007, World journal of gastroenterology.

[29]  S. Urban,et al.  Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycans , 2007 .

[30]  Wenhui Li,et al.  Sodium Taurocholate Cotransporting Polypeptide Mediates Woolly Monkey Hepatitis B Virus Infection of Tupaia Hepatocytes , 2013, Journal of Virology.

[31]  R. Gish,et al.  Chronic hepatitis B: what should be the goal for new therapies? , 2013, Antiviral research.

[32]  V. Lohmann,et al.  Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor. , 2014, Journal of hepatology.

[33]  U. Protzer,et al.  Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes. , 2013, Antiviral research.

[34]  M. Anwer,et al.  Sodium-dependent bile salt transporters of the SLC10A transporter family: more than solute transporters , 2013, Pflügers Archiv - European Journal of Physiology.

[35]  S. Urban,et al.  Efficient Inhibition of Hepatitis B Virus Infection by Acylated Peptides Derived from the Large Viral Surface Protein , 2004, Journal of Virology.

[36]  Seungtaek Kim,et al.  The FDA-Approved Drug Irbesartan Inhibits HBV-Infection in HepG2 Cells Stably Expressing Sodium Taurocholate Co-Transporting Polypeptide , 2015, Antiviral therapy.

[37]  U. Beuers,et al.  Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na+-taurocholate cotransporting polypeptide knockout mice , 2015, Hepatology.

[38]  Thomas Lütteke,et al.  The SLC10 carrier family: transport functions and molecular structure. , 2012, Current topics in membranes.

[39]  S. Chi,et al.  Pre‐structured motifs in the natively unstructured preS1 surface antigen of hepatitis B virus , 2007, Protein science : a publication of the Protein Society.

[40]  M. Quick,et al.  Structural basis of the alternating-access mechanism in a bile acid transporter , 2013, Nature.

[41]  H. Waterham,et al.  Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: Conjugated hypercholanemia without a clear clinical phenotype , 2015, Hepatology.

[42]  C. Seeger,et al.  Molecular biology of hepatitis B virus infection. , 2015, Virology.

[43]  C. Sureau,et al.  The Pre-S1 and Antigenic Loop Infectivity Determinants of the Hepatitis B Virus Envelope Proteins Are Functionally Independent , 2009, Journal of Virology.

[44]  H. Kusuhara,et al.  Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP) , 2014, Hepatology.

[45]  U. Haberkorn,et al.  Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein , 2008, Nature Biotechnology.

[46]  O. Fardel,et al.  Interleukin 6 inhibits HBV entry through NTCP down regulation. , 2015, Virology.

[47]  U. Haberkorn,et al.  Hepatitis B virus hepatotropism is mediated by specific receptor recognition in the liver and not restricted to susceptible hosts , 2013, Hepatology.

[48]  R. Lanford,et al.  Mapping of the Hepatitis B Virus Pre-S1 Domain Involved in Receptor Recognition , 2005, Journal of Virology.

[49]  T. Weiss,et al.  Myristoylated PreS1‐domain of the hepatitis B virus L‐protein mediates specific binding to differentiated hepatocytes , 2013, Hepatology.

[50]  Wenhui Li,et al.  Molecular Determinants of Hepatitis B and D Virus Entry Restriction in Mouse Sodium Taurocholate Cotransporting Polypeptide , 2013, Journal of Virology.

[51]  P. Meier,et al.  Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. , 1994, The Journal of clinical investigation.

[52]  H. Alter,et al.  Neutralization epitope responsible for the hepatitis B virus subtype-specific protection in chimpanzees. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[53]  C. Ryu,et al.  Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1. , 2000, Virology.

[54]  G. Acs,et al.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[55]  C. Sureau,et al.  Infectivity Determinants of the Hepatitis B Virus Pre-S Domain Are Confined to the N-Terminal 75 Amino Acid Residues , 2007, Journal of Virology.

[56]  Wenhui Li,et al.  Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide , 2015, PLoS pathogens.

[57]  Olivier Fardel,et al.  Regulation of Drug Transporter Expression in Human Hepatocytes Exposed to the Proinflammatory Cytokines Tumor Necrosis Factor-α or Interleukin-6 , 2009, Drug Metabolism and Disposition.

[58]  O. Fardel,et al.  Regulation of drug transporter expression by oncostatin M in human hepatocytes. , 2011, Biochemical pharmacology.

[59]  M. Schnölzer,et al.  Characterization of a hepatitis B and hepatitis delta virus receptor binding site , 2006, Hepatology.

[60]  J. Polli,et al.  A substrate pharmacophore for the human sodium taurocholate co-transporting polypeptide. , 2015, International journal of pharmaceutics.

[61]  C. Sureau,et al.  A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A‐determinant , 2013, Hepatology.

[62]  W. Gerlich,et al.  Pre-S1 Antigen-Dependent Infection of Tupaia Hepatocyte Cultures with Human Hepatitis B Virus , 2003, Journal of Virology.

[63]  H. Blum,et al.  Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo , 1996, Hepatology.

[64]  M. Manns,et al.  Primary Biliary Acids Inhibit Hepatitis D Virus (HDV) Entry into Human Hepatoma Cells Expressing the Sodium-Taurocholate Cotransporting Polypeptide (NTCP) , 2015, PloS one.

[65]  S. Urban,et al.  Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. , 2007, Hepatology.

[66]  P. Sham,et al.  The p.Ser267Phe variant in SLC10A1 is associated with resistance to chronic hepatitis B , 2015, Hepatology.

[67]  C. Guguen-Guillouzo,et al.  Myristylation of the hepatitis B virus large surface protein is essential for viral infectivity. , 1995, Virology.

[68]  Wenhui Li,et al.  Viral Entry of Hepatitis B and D Viruses and Bile Salts Transportation Share Common Molecular Determinants on Sodium Taurocholate Cotransporting Polypeptide , 2014, Journal of Virology.

[69]  S. Iwata,et al.  Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT , 2011, Nature.

[70]  C. Sureau.  The role of the HBV envelope proteins in the HDV replication cycle. , 2006, Current topics in microbiology and immunology.

[71]  W. Gerlich,et al.  Large surface proteins of hepatitis B virus containing the pre-s sequence , 1984, Journal of virology.

[72]  A. Geipel,et al.  Kinetics of the bile acid transporter and hepatitis B virus receptor Na+/taurocholate cotransporting polypeptide (NTCP) in hepatocytes. , 2014, Journal of hepatology.

[73]  A. Budkowska,et al.  Structural and functional characterization of a monoclonal antibody specific for the preS1 region of hepatitis B virus , 2001, FEBS letters.